The state murder trial of Luigi Mangione, accused of killing UnitedHealthcare CEO Brian Thompson, has been postponed indefinitely. This delay follows Mangione’s recent guilty plea to federal charges, with his lawyers seeking dismissal of the state case on double jeopardy grounds. Judge Gregory Carro canceled the trial and has given the Manhattan District Attorney’s office until October 9 to respond to the defense’s claims. A hearing is scheduled for December 10, just before Mangione’s sentencing in the federal case.
Mangione, 28, admitted to stalking Thompson and shooting him near a Manhattan hotel in 2024. Federal prosecutors plan to seek life imprisonment for Mangione, although sentencing guidelines suggest a term of 24 to 30 years. After his plea, his lawyers argued that he is being unfairly prosecuted twice for the same actions, citing both due process and double jeopardy grounds.
In the state case, Mangione pleaded not guilty, which still could lead to a life sentence. The Manhattan District Attorney, Alvin Bragg, insists on continuing the state prosecution, mainly because Mangione’s federal sentence is pending. New York law offers strong protections against multiple prosecutions, which can bar a state case if a federal guilty plea occurs under the same circumstances.
Judge Carro will decide if these protections apply to Mangione’s case, with the possibility of an appeal regardless of the decision. Mangione’s federal charges involved traveling across state lines to commit the crime, using resources such as the internet and highways to execute his plan.
While Mangione’s defense argues that the federal and state offenses are part of the same criminal episode, Bragg’s office maintains that the charges differ legally. Assistant District Attorney Joel Seidemann emphasizes that the severity of Mangione’s actions and the state’s vested interests in the case merit separate prosecution, highlighting the state’s dedication to its homicide laws.